Your browser doesn't support javascript.
loading
Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells.
Domagala, Marcin; Laplagne, Chloé; Leveque, Edouard; Laurent, Camille; Fournié, Jean-Jacques; Espinosa, Eric; Poupot, Mary.
Afiliación
  • Domagala M; Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
  • Laplagne C; Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
  • Leveque E; ERL 5294 CNRS, 31037 Toulouse, France.
  • Laurent C; Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
  • Fournié JJ; Université Toulouse III Paul-Sabatier, 31400 Toulouse, France.
  • Espinosa E; ERL 5294 CNRS, 31037 Toulouse, France.
  • Poupot M; Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, 31037 Toulouse, France.
Cancers (Basel) ; 13(2)2021 Jan 06.
Article en En | MEDLINE | ID: mdl-33418996
ABSTRACT
Interactions between malignant cells and neighboring stromal and immune cells profoundly shape cancer progression. New forms of therapies targeting these cells have revolutionized the treatment of cancer. However, in order to specifically address each population, it was essential to identify and understand their individual roles in interaction between malignant cells, and the formation of the tumor microenvironment (TME). In this review, we focus on the myeloid cell compartment, a prominent, and heterogeneous group populating TME, which can initially exert an anti-tumoral effect, but with time actively participate in disease progression. Macrophages, dendritic cells, neutrophils, myeloid-derived suppressor cells, mast cells, eosinophils, and basophils act alone or in concert to shape tumor cells resistance through cellular interaction and/or release of soluble factors favoring survival, proliferation, and migration of tumor cells, but also immune-escape and therapy resistance.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Francia